Spark Therapeutics Reports 2017 Financial Results and Recent Business Progress
Feb 20, 2018 12:30 pm UTC| Business
PHILADELPHIA, Feb. 20, 2018 -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, announced today corporate and financial results for...
Feb 20, 2018 12:30 pm UTC| Business
TAMPA, Fla., Feb. 20, 2018 -- Advanzeon Solutions, Inc. (OTCBB:CHCR) ("Advanzeon") and MYnd Analytics, Inc. (NASDAQ:MYND) announced today that Advanzeon’s wholly owned subsidiary, Pharmacy Value Management Solutions,...
Feb 20, 2018 12:30 pm UTC| Business
Actimab-MDS to be featured in a Product Theater on February 21st Members of Actinium’s executive and clinical development teams to participate in conference activities and extend the visibility of the Company’s...
Feb 20, 2018 12:30 pm UTC| Business
WASHINGTON, Feb. 20, 2018 -- FTI Consulting, Inc. (NYSE:FCN) today announced the appointment of Keith McGregor as a Senior Managing Director in the Corporate Finance Restructuring segment, continuing to deepen the...
Feb 20, 2018 12:30 pm UTC| Business
NEW YORK, Feb. 20, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of RealPage, Inc....
Daktronics, Inc. Announces Third Quarter Fiscal 2018 Results
Feb 20, 2018 12:30 pm UTC| Business
BROOKINGS, S.D., Feb. 20, 2018 -- Daktronics, Inc. (NASDAQ:DAKT) today reported fiscal 2018 third quarter net sales of $130.3 million, operating loss of $3.3 million, and net loss of $6.2 million, or $0.14 per diluted...
Feb 20, 2018 12:30 pm UTC| Business
ANN ARBOR, Mich., Feb. 20, 2018 -- Esperion (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing complementary, convenient, cost-effective, once-daily, oral therapies for the treatment...